Robert Goldstein - US Nuclear Chairman of the Board and Presidentident, CEO
| UCLE Stock | USD 0.07 0 1.41% |
Chairman
Mr. Robert I. Goldstein is Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Goldstein entered the radiation detection industry in 1972 as an applications engineer, production manager, and then general manager for Optron Scientific Company, Inc. DBA, Technical Associates. Mr. Goldstein is a physicist and an award winning specialist in the nuclear radiation detection industry has more than 30 years of experience in the field. He has authored more than 20 white papers and abstract presentations on industrial research use of radiation measurement equipment and instruments. His work was approved by US Federal standards set by the EPA, FDA, and NRC . Mr. Goldstein has also worked closely with and continues ongoing joint development programs with Los Alamos National Lab and Jefferson National Lab. He was instrumental in the acquisition of Overhoff Technology Corporationration at the time, the worlds only tritium detection company, in 2006. His experience in the field of radiation detection ranges from development of instrumentation to design and development for air, water and surface applications. He is also an accomplished inventor having invented miniature radiation detectors for use during surgery. Mr. Goldstein graduated from MIT with a BS in Physics and from Stanford University with an M.S. in Mechanical Engineering. Mr. Goldstein is affiliated with the following scientific groups Health Physics Society, American Nuclear Society, DOE Tritium Focus Group, Air Monitoring Users Group and Health Physics Instrument Committee.
| Age | 74 |
| Phone | 818 883 7043 |
| Web | https://usnuclearcorp.com |
Robert Goldstein Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Goldstein against US Nuclear pink sheet is an integral part of due diligence when investing in US Nuclear. Robert Goldstein insider activity provides valuable insight into whether US Nuclear is net buyers or sellers over its current business cycle. Note, US Nuclear insiders must abide by specific rules, including filing SEC forms every time they buy or sell US Nuclear'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Goldstein over six months ago Disposition of 100000 shares by Robert Goldstein of Las Vegas at 52.06 subject to Rule 16b-3 | ||
Robert Goldstein over six months ago Disposition of 100000 shares by Robert Goldstein of Las Vegas at 52.06 subject to Rule 16b-3 |
US Nuclear Management Efficiency
The company has return on total asset (ROA) of (0.289) % which means that it has lost $0.289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.4581) %, meaning that it created substantial loss on money invested by shareholders. US Nuclear's management efficiency ratios could be used to measure how well US Nuclear manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | CHAIRMAN Age | ||
| Thomas Wroe | Sensata Technologies Holding | 69 | |
| Kenneth Bockhorst | Badger Meter | 52 | |
| Marc Zandman | Vishay Precision Group | 59 | |
| Andrew Teich | Sensata Technologies Holding | 59 | |
| Christopher Coccio | Sono Tek Corp | 84 | |
| Alan Spoon | Fortive Corp | 68 | |
| Matthijs Glastra | Novanta | 56 | |
| Victor Richey | ESCO Technologies | 67 | |
Management Performance
| Return On Equity | -19.46 | |||
| Return On Asset | -0.29 |
US Nuclear Corp Leadership Team
Elected by the shareholders, the US Nuclear's board of directors comprises two types of representatives: US Nuclear inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UCLE. The board's role is to monitor US Nuclear's management team and ensure that shareholders' interests are well served. US Nuclear's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, US Nuclear's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Landry, COO, Director of Investor Relations, and Business Development Consultant | ||
| Robert Goldstein, Chairman of the Board and Presidentident, CEO | ||
| Ivan Mitev, Chief Corp | ||
| Dell Williamson, VP Director |
UCLE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is US Nuclear a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -19.46 | |||
| Return On Asset | -0.29 | |||
| Profit Margin | (0.52) % | |||
| Operating Margin | (0.55) % | |||
| Current Valuation | 3.72 M | |||
| Shares Outstanding | 30.16 M | |||
| Shares Owned By Insiders | 37.80 % | |||
| Price To Earning | (2.93) X | |||
| Price To Book | 9.53 X | |||
| Price To Sales | 1.80 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in UCLE Pink Sheet
US Nuclear financial ratios help investors to determine whether UCLE Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UCLE with respect to the benefits of owning US Nuclear security.